Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines

Citation
S. Srividya et al., Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines, J LEUK BIOL, 67(5), 2000, pp. 683-690
Citations number
54
Categorie Soggetti
Immunology
Journal title
JOURNAL OF LEUKOCYTE BIOLOGY
ISSN journal
07415400 → ACNP
Volume
67
Issue
5
Year of publication
2000
Pages
683 - 690
Database
ISI
SICI code
0741-5400(200005)67:5<683:SRDOMD>2.0.ZU;2-G
Abstract
We showed that muramyl dipeptide (MDP) conjugated to maleylated bovine seru m albumin (MBSA) was internalized by macrophages (M phi) through scavenger receptor (SCR)-mediated endocytosis, which leads to 50-fold higher cytotoxi c activity against non-M phi tumor cells compared with that elicited by fre e MDP-treated M phi. The enhanced cytotoxic effect of MBSA-MDP was found to be a result of higher secretion of interleukin (IL)-1, IL-6, tumor necrosi s factor alpha (TNF-alpha), and nitric oxide (NO) because the addition of a ntibodies directed against IL-1, IL-6, or TNF-alpha in combination with M p hi cultures totally abrogated the tumoricidal activity of MBSA-MDP. It is i nteresting to note that MBSA-MDP triggers the secretion of IL-12, whereas I L-10, a M phi suppressor cytokine, could be detected only on free MDP treat ment. The cytotoxic activity of MBSA-MDP was inhibited by indomethacin, ind icating a regulatory role for prostaglandin E-2 (PGE(2)), Efficient SCR-med iated intracellular delivery of MDP leading to elimination of cancer cells suggests the immunotherapeutic potential of this approach for treatment of neoplasia.